Statistics
Publications
9
Citations
802
H-Index
9
Active since
1996
Affiliations
Dawei Yang is an author at State Key Laboratory of Natural Medicine specializing in medicine, oncology, and pharmacology.
Publications per year
1996–2022
9
9
Anlotinib inhibits angiogenesis via suppressing the activation of VEGFR2, PDGFRβ and FGFR1
Binyan Lin, Xiuming Song, Dawei Yang et al. · Gene · 2018 · 396 citations
Medicine, Oncology, Pharmacology +8
Identification of lysine-lactylated substrates in gastric cancer cells
Dawei Yang, Jie Yin, Liuqun Shan et al. · iScience · 2022 · 117 citations · Full text
Genetic and Epigenetic Alterations of Familial Pancreatic Cancers
Kieran Brune, Seung‐Mo Hong, Ang Li et al. · Cancer Epidemiology Biomarkers & Prevention · 2008 · 82 citations · Full text
Wogonin induces cellular senescence in breast cancer via suppressing TXNRD2 expression
Dawei Yang, Qinglong Guo, Yin Liang et al. · Archives of Toxicology · 2020 · 63 citations
Medicine, Cell Biology, Oncology +8
Identification of GL-V9 as a novel senolytic agent against senescent breast cancer cells
Dawei Yang, Xiaoyu Tian, Yuchen Ye et al. · Life Sciences · 2021 · 47 citations
Medicine, Oncology, Pharmacology +4
1–5 of 9